1.Two cases of primary ovarian transitional cell carcinoma.
Yuan Fung SUN ; Young Woo JANG ; Yong Hwa HWANG ; Sueng Kwon KOH ; Sook CHO ; Byung Moon KANG ; Goo Sang KIM
Korean Journal of Obstetrics and Gynecology 1993;36(7):1039-1046
No abstract available.
Carcinoma, Transitional Cell*
2.Transitional cell carcinoma of the ovary-a case report-.
Journal of the Korean Cancer Association 1993;25(3):455-459
No abstract available.
Carcinoma, Transitional Cell*
3.Three Cases of Primary Ovarian Transitional Cell Carcinoma.
So Young KIM ; Young Chae CHU ; Suk Jin CHOI ; Jin Gyo LEE ; Ki Eun LEE ; Eun Seop SONG ; Sung Ook HWANG ; Moon Hee LEE ; Seok Mo KIM ; Woo Young LEE
Korean Journal of Obstetrics and Gynecology 2006;49(3):690-698
Primary ovarian transitional cell carcinoma (TCC) is extremely rare tumor and recently it has been recognized as one of histologic subtype of ovarian epithelial carcinoma. We experienced three cases at Inha University Hospital and report our experiences with a brief review of literature.
Carcinoma, Transitional Cell*
4.CT in the diagnosis of transitional cell carcinoma of the kidney.
Hye Young CHO ; On Koo CHO ; Sun Won CHOI ; Byung KOH ; Soon Yong KIM
Journal of the Korean Radiological Society 1991;27(1):108-115
No abstract available.
Carcinoma, Transitional Cell*
;
Diagnosis*
;
Kidney*
5.Prostatic involvement by transitional cell carcinoma of the bladder.
Soo Woong KIM ; Jong Bouk LEE ; Sang Eun LEE
Korean Journal of Urology 1991;32(2):239-244
No abstract available.
Carcinoma, Transitional Cell*
;
Urinary Bladder*
8.Two Cases of Primary Ovarian Transitional Cell Carcinoma.
Geong Yeol KIM ; Dogn Young LEE ; Sam Sik KIM ; Se Jin KIM ; Chun Sik JEON ; Il Soo PARK
Korean Journal of Obstetrics and Gynecology 1997;40(12):2898-2902
No abstract available.
Carcinoma, Transitional Cell*
;
Female
;
Ovary
9.A Case of Transitional Cell Carcinoma of the Remnant Ureter.
Korean Journal of Urology 1979;20(1):89-91
Herein, author describes clinical experience with one patient who had remnant ureterectomy and wide excision of bladder wall including left ureteral orifice for transitional cell carcinoma of the remnant ureter with brief review of literature.
Carcinoma, Transitional Cell*
;
Humans
;
Ureter*
;
Urinary Bladder
10.The Clinical Value of the Serum and Urinary Levels of beta-HCG in Transitional Cell Carcinoma of the Bladder.
Sang Ik LEE ; Tae Hee OH ; Hi Young SHIM
Korean Journal of Urology 1996;37(6):646-651
It has been reported that beta-HCG is produced in the transitional cell carcinoma of the bladder and measuring of its level can be used as a tumor marker. We measured the serum and urinary levels of beta-HCG in the patients with the transitional cell carcinoma of the bladder and analysed the relationship to the clinical stage and histological grade and its significance as a tumor marker. The levels of the beta-HCG in the serum and early morning urine were measured in 40 cases of transitional cell carcinoma of the bladder and 37 cases of control group. Double-antibody immunometric assay (Coat-A-Count HCG IRMA) using I-labeled anti HCG antibody and monoclonal anti HCG antibody were used. The mean levels of the serum and urinary f-HCG in control group were 1.2mIU/ml, 1.4mIU/ ml and 3.6mIU/ml, 6.0mIU/ml in patient group, which showed a statistically significant difference between the two groups(p<0.05). In patient group, the levels of the serum and urinary beta- HCG were 2.9mIU/ml and 3.5mIU/ml in the superficial tumor, 2.6mIU/ml and 7.0mIU/ml in the invasive tumor and 7.5mIU/ml and 9.9mIU/ml in the metastatic tumor, showing a statistically significant increase as the clinical stage was advanced(p <0.05). The levels of the serum and urinary beta-HCG were 3.3mIU/ml and 1.3mIU/ml in grade I, 2.9mIU/ml and 5.9mIU/ml in grade II and 4.7mIU/ml and 7.6mIU/ml in grade III, which did not demonstrate a significant relationship to the histological grade(p>0.05). We think that the serum and urinary levels of beta-HCG in the transitional cell carcinoma of the bladder are related to the tumor stage but not to the histological grade and in the metastatic tumor urinary beta-HCG level can be used as a reliable tumor marker.
Carcinoma, Transitional Cell*
;
Humans
;
Urinary Bladder*
Result Analysis
Print
Save
E-mail